BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15846251)

  • 1. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
    Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
    Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
    Glasser SP; Neutel JM; Gana TJ; Albert KS
    Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
    Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
    J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Evening Administration of Controlled-Delivery Diltiazem Capsules in Chronic Stable Angina Patients.
    Baird MG; Juneau M; Nadeau C; Clermont P; Chin C; Boulet AA
    Am J Ther; 1995 Jun; 2(6):401-406. PubMed ID: 11850684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of depot diltiazem in stable effort angina: a double-blind study compared with placebo].
    Baldi N; Guiducci U; Piccitto R
    G Ital Cardiol; 1996 May; 26(5):527-32. PubMed ID: 8767776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diltiazem in chronic stable angina].
    González-Hermosillo JA; Clemente AC; Salazar E
    Arch Inst Cardiol Mex; 1986; 56(4):327-32. PubMed ID: 2945527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram].
    Metra M; Catalano A; Danesi R; Furloni R; Cuminetti S; Bellandi M; Dei Cas L
    Cardiologia; 1992 Jun; 37(6):403-11. PubMed ID: 1394348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
    Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
    de Caprio L; Sestito M; Pandolfi E; Santamaria F; di Palma A; Lombardi L; Voza A; De Rosa ML; Cicatiello AM; Rengo F
    G Ital Cardiol; 1994 Feb; 24(2):115-22. PubMed ID: 8013763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
    Thadani U; Glasser S; Bittar N; Beach CL
    Am J Cardiol; 1994 Jul; 74(1):9-17. PubMed ID: 8017316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.